4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide

C124H114F3N29O12 — CID 160592949

IUPAC4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide
SMILESCN(C(=O)/C=C/CN(C)C1CC1)c1cccc(-n2c(=O)n(-c3ccc(Oc4ccccc4)nc3)c3c(N)ncnc32)c1.CN(C(=O)/C=C/CN1CCOCC1)c1cccc(-n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)c1.CN(C)C/C=C/CN(C)c1cccc(-n2c(=O)n(-c3ccc(C(=O)Nc4cccc(C(F)(F)F)c4)cc3)c3c(N)ncnc32)c1.Cc1cccn(-c2cccc(-n3c(=O)n(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)c2)c1=O
InChIInChI=1S/C32H31F3N8O2.C32H31N7O4.C31H30N8O3.C29H22N6O3/c1-40(2)16-4-5-17-41(3)25-10-7-11-26(19-25)43-29-27(28(36)37-20-38-29)42(31(43)45)24-14-12-21(13-15-24)30(44)39-23-9-6-8-22(18-23)32(33,34)35;1-36(28(40)11-6-16-37-17-19-42-20-18-37)24-7-5-8-25(21-24)39-31-29(30(33)34-22-35-31)38(32(39)41)23-12-14-27(15-13-23)43-26-9-3-2-4-10-26;1-36(21-13-14-21)17-7-12-27(40)37(2)22-8-6-9-23(18-22)39-30-28(29(32)34-20-35-30)38(31(39)41)24-15-16-26(33-19-24)42-25-10-4-3-5-11-25;1-19-7-6-16-33(28(19)36)21-8-5-9-22(17-21)35-27-25(26(30)31-18-32-27)34(29(35)37)20-12-14-24(15-13-20)38-23-10-3-2-4-11-23/h4-15,18-20H,16-17H2,1-3H3,(H,39,44)(H2,36,37,38);2-15,21-22H,16-20H2,1H3,(H2,33,34,35);3-12,15-16,18-21H,13-14,17H2,1-2H3,(H2,32,34,35);2-18H,1H3,(H2,30,31,32)/b5-4+;11-6+;12-7+;
InChIKeyRDGMTAGLBLILTM-QAHGJFIQSA-N
MW2259.46 g/mol
LogP17.14
Rot. Bonds31

About 4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide

4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide (PubChem CID 160592949) has the molecular formula C124H114F3N29O12 and a molecular weight of 2259.46 g/mol. Its IUPAC name is 4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide.

Molecular Properties

Compound Name4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide
PubChem CID160592949
Molecular FormulaC124H114F3N29O12
Molecular Weight2259.46 g/mol
Exact Mass2257.92
IUPAC Name4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide
SMILESCN(C(=O)/C=C/CN(C)C1CC1)c1cccc(-n2c(=O)n(-c3ccc(Oc4ccccc4)nc3)c3c(N)ncnc32)c1.CN(C(=O)/C=C/CN1CCOCC1)c1cccc(-n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)c1.CN(C)C/C=C/CN(C)c1cccc(-n2c(=O)n(-c3ccc(C(=O)Nc4cccc(C(F)(F)F)c4)cc3)c3c(N)ncnc32)c1.Cc1cccn(-c2cccc(-n3c(=O)n(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)c2)c1=O
InChIInChI=1S/C32H31F3N8O2.C32H31N7O4.C31H30N8O3.C29H22N6O3/c1-40(2)16-4-5-17-41(3)25-10-7-11-26(19-25)43-29-27(28(36)37-20-38-29)42(31(43)45)24-14-12-21(13-15-24)30(44)39-23-9-6-8-22(18-23)32(33,34)35;1-36(28(40)11-6-16-37-17-19-42-20-18-37)24-7-5-8-25(21-24)39-31-29(30(33)34-22-35-31)38(32(39)41)23-12-14-27(15-13-23)43-26-9-3-2-4-10-26;1-36(21-13-14-21)17-7-12-27(40)37(2)22-8-6-9-23(18-22)39-30-28(29(32)34-20-35-30)38(31(39)41)24-15-16-26(33-19-24)42-25-10-4-3-5-11-25;1-19-7-6-16-33(28(19)36)21-8-5-9-22(17-21)35-27-25(26(30)31-18-32-27)34(29(35)37)20-12-14-24(15-13-20)38-23-10-3-2-4-11-23/h4-15,18-20H,16-17H2,1-3H3,(H,39,44)(H2,36,37,38);2-15,21-22H,16-20H2,1H3,(H2,33,34,35);3-12,15-16,18-21H,13-14,17H2,1-2H3,(H2,32,34,35);2-18H,1H3,(H2,30,31,32)/b5-4+;11-6+;12-7+;
InChIKeyRDGMTAGLBLILTM-QAHGJFIQSA-N
XLogP17.14
TPSA469.41 Ų
H-Bond Donors5
H-Bond Acceptors38
Rotatable Bonds31
Heavy Atoms168
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002259.46
LogP ≤ 517.14
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1038

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide?
The IUPAC name of 4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide (CID 160592949) is 4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide.
What is the SMILES notation for 4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide?
The canonical SMILES for 4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide is CN(C(=O)/C=C/CN(C)C1CC1)c1cccc(-n2c(=O)n(-c3ccc(Oc4ccccc4)nc3)c3c(N)ncnc32)c1.CN(C(=O)/C=C/CN1CCOCC1)c1cccc(-n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)c1.CN(C)C/C=C/CN(C)c1cccc(-n2c(=O)n(-c3ccc(C(=O)Nc4cccc(C(F)(F)F)c4)cc3)c3c(N)ncnc32)c1.Cc1cccn(-c2cccc(-n3c(=O)n(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)c2)c1=O.
What is the InChIKey of 4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide?
The InChIKey is RDGMTAGLBLILTM-QAHGJFIQSA-N. The full InChI is InChI=1S/C32H31F3N8O2.C32H31N7O4.C31H30N8O3.C29H22N6O3/c1-40(2)16-4-5-17-41(3)25-10-7-11-26(19-25)43-29-27(28(36)37-20-38-29)42(31(43)45)24-14-12-21(13-15-24)30(44)39-23-9-6-8-22(18-23)32(33,34)35;1-36(28(40)11-6-16-37-17-19-42-20-18-37)24-7-5-8-25(21-24)39-31-29(30(33)34-22-35-31)38(32(39)41)23-12-14-27(15-13-23)43-26-9-3-2-4-10-26;1-36(21-13-14-21)17-7-12-27(40)37(2)22-8-6-9-23(18-22)39-30-28(29(32)34-20-35-30)38(31(39)41)24-15-16-26(33-19-24)42-25-10-4-3-5-11-25;1-19-7-6-16-33(28(19)36)21-8-5-9-22(17-21)35-27-25(26(30)31-18-32-27)34(29(35)37)20-12-14-24(15-13-20)38-23-10-3-2-4-11-23/h4-15,18-20H,16-17H2,1-3H3,(H,39,44)(H2,36,37,38);2-15,21-22H,16-20H2,1H3,(H2,33,34,35);3-12,15-16,18-21H,13-14,17H2,1-2H3,(H2,32,34,35);2-18H,1H3,(H2,30,31,32)/b5-4+;11-6+;12-7+;.
What are the key properties of 4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide?
4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide has a molecular weight of 2259.46 g/mol, XLogP of 17.14, 31 rotatable bonds, 5 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[6-amino-9-[3-[[(E)-4-(dimethylamino)but-2-enyl]-methylamino]phenyl]-8-oxopurin-7-yl]-N-[3-(trifluoromethyl)phenyl]benzamide;6-amino-9-[3-(3-methyl-2-oxo-1-pyridinyl)phenyl]-7-(4-phenoxyphenyl)purin-8-one;(E)-N-[3-[6-amino-8-oxo-7-(4-phenoxyphenyl)purin-9-yl]phenyl]-N-methyl-4-morpholin-4-ylbut-2-enamide;(E)-N-[3-[6-amino-8-oxo-7-(6-phenoxy-3-pyridinyl)purin-9-yl]phenyl]-4-[cyclopropyl(methyl)amino]-N-methylbut-2-enamide is sourced from PubChem (CID 160592949), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).